Skip to search formSkip to main contentSkip to account menu

milacemide

Known as: 2-n-pentylaminoacetamide 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2000
Highly Cited
2000
The study of excitatory amino acids (EAA) [e.g. glutamate (Glu), aspartate] as neurotransmitters has resulted in many new and… 
1992
1992
1 Milacemide is a glycine prodrug which is both an inhibitor and a substrate for monoamine oxidase‐type B (MAO‐B) and also an… 
1992
1992
Prior research has shown that memory for facts and items (item memory) and memory for where one has learned these items (source… 
1991
1991
Interest in the NMDA receptor as a key mechanism in long-term potentiation and possibly improved learning and memory has led to… 
1988
1988
Until the early seventies, it was generally believed that normal brain function would be unaffected by the metabolic changes… 
Highly Cited
1988
Highly Cited
1988
Abstract: Milacemide (2‐n‐pentylaminoacetamide) is a secondary monoamine that in the brain is converted to glycinamide and… 
1983
1983
The anticonvulsant activity of a new drug, milacemide (2-(pentylamino)-acetamide), has been studied in animal models of…